Combination of three technologies makes potential treatment effective against aggressive brain tumor

By | June 15, 2022
A drug carrier able to reach the brain, bind to an aggressive type of tumor called glioblastoma multiforme, and release a chemotherapeutic agent has been tested for the first time by Brazilian researchers.